05:14 PM EDT, 10/22/2025 (MT Newswires) -- Michael R Megna, Chief Accounting Officer, on October 20, 2025, sold 50,490 shares in Kiniksa Pharmaceuticals International ( KNSA ) for $1,962,781. Following the Form 4 filing with the SEC, Megna has control over a total of 27,046 Class A ordinary shares of the company, with 27,046 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1730430/000146458325000005/xslF345X05/form4-10222025_091045.xml